Wikipedia -WSS

Wikipedia

author：explore 2025-09-30 14:08:51 - browse：892

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Hospitals warn Medicare's drug payment fix is ‘unlawful’

hotspot

explore

WSS

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Medicare inequities exacerbate Puerto Rico’s health disparities

Telehealth options flood the market as retailers push virtual care

CDC recommends rationing of RSV shot due to shortages

focus

Wikipedia

knowledge

At least 13 dead in Texas as scorching temps continue

First Opinion Podcast: How to protect health care in times of war

Peter Hotez and the public health issue of online harassment

Chimpanzees, like humans and whales, get menopause: Study

Novavax promises a turnaround & Lilly roils the obesity market

NIH study of ME/CFS points to clear biological hallmarks

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare inequities exacerbate Puerto Rico’s health disparities

Tori Bowie and the unacceptable rates of Black maternal death

Alabama IVF ruling threatens families facing fatal genetic disease

hotspot

STAT readers on older presidents, polypills, Medicare, and more

Dario to buy mental health app maker Twill in cash and stock deal

PBM reform efforts get punted in Congress

Physician subsidies by hospitals soar in wake of No Surprises Act

Why Sanofi got shellacked over its spinoff

A new nitrogen execution bill also undermines medical licensing

hotspot

explore

explore

knowledge